Navigation Links
Orthotrac Pneumatic Vest

ProductsOrthotrac Pneumatic Vest
Company Orthofix, Inc
Item Orthotrac Pneumatic Vest
Features 
  • Orthotrac is the only ambulatory device shown to unload the spine.
  • When the Orthotrac is used, the actual difference in space is typically one millimeter, which is sufficient to unload the spine in most cases.
  • The Orthotrac Pneumatic Vest is indicated for any discogenic pain, mechanical low back pain or radicular pain diagnosis that would benefit from lumbar spinal unloading.
    • Description Now there is an option beyond traditional methods for patients who are drowning in chronic low back pain. The new Orthotrac Pneumatic Vest effectively alleviates intervertebral compression and chronic back pain. In fact, associated leg pain is often relieved within minutes of application. The Orthotrac is the only ambulatory treatment shown to decompress the spine. Using patented, patient- administered pneumatic lifting, the vest is designed to lift a weight equal to 30% to 50% of body weight from the lumbar spine onto the iliac crests. A recent study of over 300 patients resulted in a significant (p< 0.01) functional improvement of 70% along with a significant (p<0.01) decrease of 28% in reported pain. Orthotrac can can also decrease the cost of low back pain treatment. A recently published study showed that the Orthotrac vest reduced the total overall cost per patient from $6,138 to $3,699. The Orthotrac vest is designed to provide ambulatory treatment and reduce pain; allowing patients to return to work and to their daily lifestyle with improved quality of life.
    Info Orthofix, Inc
    Customer Service: (800) 535-4492
    Web site: http://www.orthofix.com

    Related medicine products :

    1. SCD Sequential Compression System Intermittent Pneumatic Compression
    2. Pneumatic Armband
    3. PneumaticWalker™ Diabetic System
    4. PneumaticWalker™
    5. Series 1000 Pneumatic Modular Instrument System
    6. Pneumatic Motor Module w/ Hand Throttle
    7. Pneumatic Motor Module, Throttleless
    8. Small Bone Pneumatic Power System
    9. Throttless Pneumatic High Speed Drill
    10. Pneumatic High Speed Drill
    11. 3.5V Pneumatic Otoscope
    Budde retractor blades are designed for the retraction of nerves, vessels, delicate tissue and basal lesions, as well as brain retraction. Equalized brain retraction pressure. Decreased shear injury
    The Budde Halo Retractor Side Rail Support is designed for the adaptation and attachment of the Budde Halo Brain Retractor System to the operating room table when a conventional skull clamp is not us
    Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm).
    Scoville Ruptured Disc Curettes, length 10" (254 mm), cup size 4 x 10 mm.
    Medicine Products:
    (Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
    (Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
    (Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
    (Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
    Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
    ...A recent research survey conducted by The Melbourn... weigh an average three kilograms more than those ...VicHealth//. The survey included 4913 people foun...essential role in obesity. The quality of footpat...
    ...Researchers found that altruistic nature where hig...milies who had less food and also had the habit of...ere the basis for origin of holiday giving. Michae...city is arguably the foundational basis of coopera...
    ...Even after the implementation of the Human Organ T...n organs, instances of ‘organ theft’ only reflect ...tem//. The recent report of bilateral kidney retri...er in Bihar has created much panic in the State. ...
    ...The activity of the brain has been mapped for the ...rostimulation//. The new procedure, developed by s...in Tübingen, accurately maps the activity in prima...lood Oxygen Level Dependent Signal). The combinati...
    Other Medicine News:Health News:Both Kidneys Robbed From A Poor Rickshaw Driver In Bihar 2Health News:New Procedure Reveals the Secrets of the Brain 2
    (Date:10/7/2008)... Texas, Oct. 7 /- The Texas Cardiac A...Center has been selected as one of,only a few site...clinical,trial for a new device to treat persisten...tment, training and research center specializing i... St. David,s Medical Center and,Texas Cardiovascul...
    (Date:10/7/2008)...inical study of adults, VYVANSE taken once-daily s...one week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstC...lobal specialty biopharmaceutical company, today,a...ssue of the Journal of,Clinical Psychiatry found o... Deficit Hyperactivity Disorder (ADHD) symptoms in...
    (Date:10/7/2008)... abstracts highlighting CIMZIA,s long-term benefit...patients presented at American College,of Gastroen...FirstCall/ -- Data from two studies,presented this...rology,(ACG) Annual Meeting demonstrate that CIMZI...i-TNF alpha (Tumor Necrosis Factor alpha) - provid...
    (Date:10/7/2008)...…RD, Denmark, October 7 /-,...ntrolled Phase II Study,Shows Statistically Signif...has now evaluated the mature phase II data from th...OSTVAC(TM) that had been,obtained as part of the r...er Institute (NCI) in the US., The results from t...
    Breaking Medicine Technology:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5How secondary sex characters can drive the origin of species 4593 1How secondary sex characters can drive the origin of species 4593 2How secondary sex characters can drive the origin of species 4593 3VioQuest Pharmaceuticals Inc Q2 08 Review Issued by Scimitar Equity LLC 7299 1VioQuest Pharmaceuticals Inc Q2 08 Review Issued by Scimitar Equity LLC 7299 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS T 2883 1Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS T 2883 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS T 2883 3New Dual Wavelength X ray Diffractometer From Oxford Diffraction Now a Part of Varian Inc Allows Increased Throughput for Challenging Single Cryst 7294 1New Dual Wavelength X ray Diffractometer From Oxford Diffraction Now a Part of Varian Inc Allows Increased Throughput for Challenging Single Cryst 7294 2
    ...r Bleeding in Patients Treated for Acute Coronary ...t One Year, NEW ORLEANS, March 26, 2007 /PRNewswir...rial show that acute coronary syndrome,(ACS) patie...ment,group had similar rates of ischemic clinical ...herapy, confirming previous findings,which showed...
    ...ial Analysis Shows Statistically Significant Chang...O, Calif., March 26, 2007 /PRNewswire-FirstCall/ -...itive initial,results from its Phase IIa clinical ...renic patients with acute agitation. The 10 mg,dos...al trial,which was a statistically-significant re...
    Other Medicine Technology:Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6